APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Albendazole

Albendazole is a high-efficiency and low-toxic broad-spectrum anthelmintic drug. It was successfully developed and marketed by Skipper in the 1980s. It can be used clinically to ward off roundworms, pinworms, tapeworms, whipworms, hookworms, and anastomosis. After being metabolized to sulfoxides or sulfones in the body, it inhibits the parasite's absorption of glucose, leading to depletion of the body's glycogen, or inhibits the fumarate reductase system, hinders the production of ATP, and makes the parasite unable to survive and reproduce. Albendazole is a benzimidazole derivative, which is rapidly metabolized into sulfoxide, sulfone alcohol and 2-aminosulfone alcohol in the body, selectively and irreversibly inhibits the cytoplasmic microtubule system of intestinal wall cells of parasites Polymerization, blocking its uptake of various nutrients and glucose, leading to depletion of endogenous glycogen, and inhibiting the fumarate reductase system, preventing the production of adenosine triphosphate, making the worm unable to survive and reproduce. Similar to mebendazole, albendazole can also cause the degeneration of cytoplasmic microtubules in the intestinal cells of worms and bind to its tubulin, causing intracellular transport blockage, resulting in the accumulation of secretory particles in the Golgi body, the cytoplasm is gradually dissolved, and the cells are completely absorbed Denaturation causes death of the worm. Albendazole completely kills hookworm eggs and whipworm eggs and partially kills roundworm eggs. In addition to killing and repelling various nematodes parasitic in animals, it also has obvious killing and repelling effects on tapeworms and cysticercosis.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Albendazole is a high-efficiency and low-toxic broad-spectrum anthelmintic drug. It was successfully developed and marketed by Skipper in the 1980s. It can be used clinically to ward off roundworms, pinworms, tapeworms, whipworms, hookworms, and anastomosis. After being metabolized to sulfoxides or sulfones in the body, it inhibits the parasite's absorption of glucose, leading to depletion of the body's glycogen, or inhibits the fumarate reductase system, hinders the production of ATP, and makes the parasite unable to survive and reproduce. Albendazole is a benzimidazole derivative, which is rapidly metabolized into sulfoxide, sulfone alcohol and 2-aminosulfone alcohol in the body, selectively and irreversibly inhibits the cytoplasmic microtubule system of intestinal wall cells of parasites Polymerization, blocking its uptake of various nutrients and glucose, leading to depletion of endogenous glycogen, and inhibiting the fumarate reductase system, preventing the production of adenosine triphosphate, making the worm unable to survive and reproduce. Similar to mebendazole, albendazole can also cause the degeneration of cytoplasmic microtubules in the intestinal cells of worms and bind to its tubulin, causing intracellular transport blockage, resulting in the accumulation of secretory particles in the Golgi body, the cytoplasm is gradually dissolved, and the cells are completely absorbed Denaturation causes death of the worm. Albendazole completely kills hookworm eggs and whipworm eggs and partially kills roundworm eggs. In addition to killing and repelling various nematodes parasitic in animals, it also has obvious killing and repelling effects on tapeworms and cysticercosis.

Selected research

Market Structure

Global Albendazole Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173961490328 December 2025198 pages

Choose your research edition.

Industry ResearchAlbendazole Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Albendazole Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Albendazole Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Albendazole Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Albendazole Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Albendazole is a high-efficiency and low-toxic broad-spectrum anthelmintic drug. It was successfully developed and marketed by Skipper in the 1980s. It can be used clinically to ward off roundworms, pinworms, tapeworms, whipworms, hookworms, and anastomosis. After being metabolized to sulfoxides or sulfones in the body, it inhibits the parasite's absorption of glucose, leading to depletion of the body's glycogen, or inhibits the fumarate reductase system, hinders the production of ATP, and makes the parasite unable to survive and reproduce. Albendazole is a benzimidazole derivative, which is rapidly metabolized into sulfoxide, sulfone alcohol and 2-aminosulfone alcohol in the body, selectively and irreversibly inhibits the cytoplasmic microtubule system of intestinal wall cells of parasites Polymerization, blocking its uptake of various nutrients and glucose, leading to depletion of endogenous glycogen, and inhibiting the fumarate reductase system, preventing the production of adenosine triphosphate, making the worm unable to survive and reproduce. Similar to mebendazole, albendazole can also cause the degeneration of cytoplasmic microtubules in the intestinal cells of worms and bind to its tubulin, causing intracellular transport blockage, resulting in the accumulation of secretory particles in the Golgi body, the cytoplasm is gradually dissolved, and the cells are completely absorbed Denaturation causes death of the worm. Albendazole completely kills hookworm eggs and whipworm eggs and partially kills roundworm eggs. In addition to killing and repelling various nematodes parasitic in animals, it also has obvious killing and repelling effects on tapeworms and cysticercosis.

This is a relatively concentrated market, mainly due to the particularity of the pharmaceutical industry, where there are higher operating licenses and barriers, technical barriers, capital barriers and environmental barriers, so the concentration is higher. From the perspective of the global market, the original research firm GSK's albendazole accounts for more than 40% of the entire industry and is the leading enterprise in the albendazole industry. From the perspective of the Chinese market, the market concentration is also relatively high. The main companies are Huazhong Pharmaceutical and Jiangsu Qihui, which together account for 70% of the domestic market.

This report provides an overview of the global Albendazole market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Albendazole and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Albendazole sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Albendazole market size, projected growth trends, production technologies, key applications, and end-use industries.

Albendazole Segment by Company

GlaxoSmithKline

Huazhong Pharmaceutical

Jiangsu Qihui

Sequent Scientific

K.A. Malle Pharmaceuticals

Lasa Supergenerics Limited

Zhongjia Pharmaceutical

Fredun Pharmaceuticals Ltd

Supharma Chem

Salius Pharma

Albendazole Segment by Type

Tablet

Capsule

Other

Albendazole Segment by Application

Human

Veterinary

Albendazole Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Albendazole market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Albendazole and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Albendazole.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Albendazole market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Albendazole manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Albendazole in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Albendazole in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Albendazole Industry Trends Table 2. Albendazole Industry Drivers Table 3. Albendazole Industry Opportunities and Challenges Table 4. Albendazole Industry Restraints Table 5. Global Albendazole Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Albendazole Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Albendazole Sales by Manufacturers (K MT) & (2021-2026) Table 8. Global Albendazole Sales Market Share by Manufacturers Table 9. Global Albendazole Average Sales Price (USD/MT) of Manufacturers (2021-2026) Table 10. Global Albendazole Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Albendazole Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Albendazole Manufacturers, Product Type & Application Table 13. Global Albendazole Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Albendazole by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tablet Table 17. Major Manufacturers of Capsule Table 18. Major Manufacturers of Other Table 19. Global Albendazole Sales by Type 2021 VS 2025 VS 2032 (K MT) Table 20. Global Albendazole Sales by Type (2021-2026) & (K MT) Table 21. Global Albendazole Sales by Type (2027-2032) & (K MT) Table 22. Global Albendazole Sales Market Share by Type (2021-2026) Table 23. Global Albendazole Sales Market Share by Type (2027-2032) Table 24. Global Albendazole Revenue by Type 2021 VS 2025 VS 2032 (K MT) Table 25. Global Albendazole Revenue by Type (2021-2026) & (K MT) Table 26. Global Albendazole Revenue by Type (2027-2032) & (K MT) Table 27. Global Albendazole Revenue Market Share by Type (2021-2026) Table 28. Global Albendazole Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Human Table 30. Major Manufacturers of Veterinary Table 31. Global Albendazole Sales by Application 2021 VS 2025 VS 2032 (K MT) Table 32. Global Albendazole Sales by Application (2021-2026) & (K MT) Table 33. Global Albendazole Sales by Application (2027-2032) & (K MT) Table 34. Global Albendazole Sales Market Share by Application (2021-2026) Table 35. Global Albendazole Sales Market Share by Application (2027-2032) Table 36. Global Albendazole Revenue by Application 2021 VS 2025 VS 2032 (K MT) Table 37. Global Albendazole Revenue by Application (2021-2026) & (K MT) Table 38. Global Albendazole Revenue by Application (2027-2032) & (K MT) Table 39. Global Albendazole Revenue Market Share by Application (2021-2026) Table 40. Global Albendazole Revenue Market Share by Application (2027-2032) Table 41. Global Albendazole Sales by Region: 2021 VS 2025 VS 2032 (K MT) Table 42. Global Albendazole Sales by Region (2021-2026) & (K MT) Table 43. Global Albendazole Sales Market Share by Region (2021-2026) Table 44. Global Albendazole Sales Forecasted by Region (2027-2032) & (K MT) Table 45. Global Albendazole Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Albendazole Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K MT) Table 47. North America Albendazole Sales by Country (2021-2026) & (K MT) Table 48. North America Albendazole Sales by Country (2027-2032) & (K MT) Table 49. Europe Albendazole Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K MT) Table 50. Europe Albendazole Sales by Country (2021-2026) & (K MT) Table 51. Europe Albendazole Sales by Country (2027-2032) & (K MT) Table 52. Asia Pacific Albendazole Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K MT) Table 53. Asia Pacific Albendazole Sales by Country (2021-2026) & (K MT) Table 54. Asia Pacific Albendazole Sales by Country (2027-2032) & (K MT) Table 55. South America, Middle East and Africa Albendazole Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K MT) Table 56. South America, Middle East and Africa Albendazole Sales by Country (2021-2026) & (K MT) Table 57. South America, Middle East and Africa Albendazole Sales by Country (2027-2032) & (K MT) Table 58. Global Albendazole Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Albendazole Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Albendazole Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Albendazole Revenue Market Share by Region (2021-2026) Table 62. Global Albendazole Revenue Market Share by Region (2027-2032) Table 63. GlaxoSmithKline Company Information Table 64. GlaxoSmithKline Business Overview Table 65. GlaxoSmithKline Albendazole Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. GlaxoSmithKline Albendazole Product Portfolio Table 67. GlaxoSmithKline Recent Development Table 68. Huazhong Pharmaceutical Company Information Table 69. Huazhong Pharmaceutical Business Overview Table 70. Huazhong Pharmaceutical Albendazole Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Huazhong Pharmaceutical Albendazole Product Portfolio Table 72. Huazhong Pharmaceutical Recent Development Table 73. Jiangsu Qihui Company Information Table 74. Jiangsu Qihui Business Overview Table 75. Jiangsu Qihui Albendazole Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Jiangsu Qihui Albendazole Product Portfolio Table 77. Jiangsu Qihui Recent Development Table 78. Sequent Scientific Company Information Table 79. Sequent Scientific Business Overview Table 80. Sequent Scientific Albendazole Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Sequent Scientific Albendazole Product Portfolio Table 82. Sequent Scientific Recent Development Table 83. K.A. Malle Pharmaceuticals Company Information Table 84. K.A. Malle Pharmaceuticals Business Overview Table 85. K.A. Malle Pharmaceuticals Albendazole Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. K.A. Malle Pharmaceuticals Albendazole Product Portfolio Table 87. K.A. Malle Pharmaceuticals Recent Development Table 88. Lasa Supergenerics Limited Company Information Table 89. Lasa Supergenerics Limited Business Overview Table 90. Lasa Supergenerics Limited Albendazole Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Lasa Supergenerics Limited Albendazole Product Portfolio Table 92. Lasa Supergenerics Limited Recent Development Table 93. Zhongjia Pharmaceutical Company Information Table 94. Zhongjia Pharmaceutical Business Overview Table 95. Zhongjia Pharmaceutical Albendazole Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Zhongjia Pharmaceutical Albendazole Product Portfolio Table 97. Zhongjia Pharmaceutical Recent Development Table 98. Fredun Pharmaceuticals Ltd Company Information Table 99. Fredun Pharmaceuticals Ltd Business Overview Table 100. Fredun Pharmaceuticals Ltd Albendazole Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Fredun Pharmaceuticals Ltd Albendazole Product Portfolio Table 102. Fredun Pharmaceuticals Ltd Recent Development Table 103. Supharma Chem Company Information Table 104. Supharma Chem Business Overview Table 105. Supharma Chem Albendazole Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Supharma Chem Albendazole Product Portfolio Table 107. Supharma Chem Recent Development Table 108. Salius Pharma Company Information Table 109. Salius Pharma Business Overview Table 110. Salius Pharma Albendazole Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Salius Pharma Albendazole Product Portfolio Table 112. Salius Pharma Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Albendazole Distributors List Table 116. Albendazole Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Albendazole Product Image Figure 2. Global Albendazole Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Albendazole Market Size (2021-2032) & (US$ Million) Figure 4. Global Albendazole Sales (2021-2032) & (K MT) Figure 5. Global Albendazole Average Price (USD/MT) & (2021-2032) Figure 6. Global Top 5 and 10 Albendazole Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tablet Image Figure 9. Capsule Image Figure 10. Other Image Figure 11. Global Albendazole Sales by Type (2021 VS 2025 VS 2032) & (K MT) Figure 12. Global Albendazole Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Albendazole Sales Market Share by Type (2021-2032) Figure 14. Global Albendazole Revenue by Type (2021 VS 2025 VS 2032) & (K MT) Figure 15. Global Albendazole Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Albendazole Revenue Market Share by Type (2021-2032) Figure 17. Human Image Figure 18. Veterinary Image Figure 19. Global Albendazole Sales by Application (2021 VS 2025 VS 2032) & (K MT) Figure 20. Global Albendazole Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Albendazole Sales Market Share by Application (2021-2032) Figure 22. Global Albendazole Revenue by Application (2021 VS 2025 VS 2032) & (K MT) Figure 23. Global Albendazole Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Albendazole Revenue Market Share by Application (2021-2032) Figure 25. North America Albendazole Sales and Growth Rate (2021-2032) & (K MT) Figure 26. North America Albendazole Sales Market Share by Country (2021-2032) Figure 27. U.S. Albendazole Sales and Growth Rate (2021-2032) & (K MT) Figure 28. Canada Albendazole Sales and Growth Rate (2021-2032) & (K MT) Figure 29. Mexico Albendazole Sales and Growth Rate (2021-2032) & (K MT) Figure 30. Europe Albendazole Sales and Growth Rate (2021-2032) & (K MT) Figure 31. Europe Albendazole Sales Market Share by Country (2021-2032) Figure 32. Germany Albendazole Sales and Growth Rate (2021-2032) & (K MT) Figure 33. France Albendazole Sales and Growth Rate (2021-2032) & (K MT) Figure 34. U.K. Albendazole Sales and Growth Rate (2021-2032) & (K MT) Figure 35. Italy Albendazole Sales and Growth Rate (2021-2032) & (K MT) Figure 36. Netherlands Albendazole Sales and Growth Rate (2021-2032) & (K MT) Figure 37. Asia Pacific Albendazole Sales and Growth Rate (2021-2032) & (K MT) Figure 38. Asia Pacific Albendazole Sales Market Share by Country (2021-2032) Figure 39. China Albendazole Sales and Growth Rate (2021-2032) & (K MT) Figure 40. Japan Albendazole Sales and Growth Rate (2021-2032) & (K MT) Figure 41. South Korea Albendazole Sales and Growth Rate (2021-2032) & (K MT) Figure 42. Southeast Asia Albendazole Sales and Growth Rate (2021-2032) & (K MT) Figure 43. India Albendazole Sales and Growth Rate (2021-2032) & (K MT) Figure 44. Australia Albendazole Sales and Growth Rate (2021-2032) & (K MT) Figure 45. South America, Middle East and Africa Albendazole Sales and Growth Rate (2021-2032) & (K MT) Figure 46. South America, Middle East and Africa Albendazole Sales Market Share by Country (2021-2032) Figure 47. Brazil Albendazole Sales and Growth Rate (2021-2032) & (K MT) Figure 48. South Africa Albendazole Sales and Growth Rate (2021-2032) & (K MT) Figure 49. Saudi Arabia Albendazole Sales and Growth Rate (2021-2032) & (K MT) Figure 50. Turkey Albendazole Sales and Growth Rate (2021-2032) & (K MT) Figure 51. Argentina Albendazole Sales and Growth Rate (2021-2032) & (K MT) Figure 52. UAE Albendazole Sales and Growth Rate (2021-2032) & (K MT) Figure 53. Egypt Albendazole Sales and Growth Rate (2021-2032) & (K MT) Figure 54. Chile Albendazole Sales and Growth Rate (2021-2032) & (K MT) Figure 55. Global Albendazole Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Albendazole Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Albendazole Revenue (2021-2032) & (US$ Million) Figure 58. North America Albendazole Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Albendazole Revenue (2021-2032) & (US$ Million) Figure 60. Europe Albendazole Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Albendazole Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Albendazole Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Albendazole Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Albendazole Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Albendazole Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Albendazole Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Capsule
  • Other
Applications
  • Human
  • Veterinary
Companies covered
  • GlaxoSmithKline
  • Huazhong Pharmaceutical
  • Jiangsu Qihui
  • Sequent Scientific
  • K.A. Malle Pharmaceuticals
  • Lasa Supergenerics Limited
  • Zhongjia Pharmaceutical
  • Fredun Pharmaceuticals Ltd
  • Supharma Chem
  • Salius Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Albendazole Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Albendazole Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Albendazole Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Albendazole Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Albendazole Market Dynamics
  1. 2.1 Albendazole Industry Trends
  2. 2.2 Albendazole Industry Drivers
  3. 2.3 Albendazole Industry Opportunities and Challenges
  4. 2.4 Albendazole Industry Restraints
3 Albendazole Market by Manufacturers
  1. 3.1 Global Albendazole Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Albendazole Sales by Manufacturers (2021-2026)
  3. 3.3 Global Albendazole Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Albendazole Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Albendazole Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Albendazole Manufacturers, Product Type & Application
  7. 3.7 Global Albendazole Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Albendazole Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Albendazole Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Albendazole Tier 1, Tier 2, and Tier 3
4 Albendazole Market by Type
  1. 4.1 Albendazole Type Introduction
  2. 4.1.1 Tablet
  3. 4.1.2 Capsule
  4. 4.1.3 Other
  5. 4.2 Global Albendazole Sales by Type
  6. 4.2.1 Global Albendazole Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Albendazole Sales by Type (2021-2032)
  8. 4.2.3 Global Albendazole Sales Market Share by Type (2021-2032)
  9. 4.3 Global Albendazole Revenue by Type
  10. 4.3.1 Global Albendazole Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Albendazole Revenue by Type (2021-2032)
  12. 4.3.3 Global Albendazole Revenue Market Share by Type (2021-2032)
5 Albendazole Market by Application
  1. 5.1 Albendazole Application Introduction
  2. 5.1.1 Human
  3. 5.1.2 Veterinary
  4. 5.2 Global Albendazole Sales by Application
  5. 5.2.1 Global Albendazole Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Albendazole Sales by Application (2021-2032)
  7. 5.2.3 Global Albendazole Sales Market Share by Application (2021-2032)
  8. 5.3 Global Albendazole Revenue by Application
  9. 5.3.1 Global Albendazole Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Albendazole Revenue by Application (2021-2032)
  11. 5.3.3 Global Albendazole Revenue Market Share by Application (2021-2032)
6 Global Albendazole Sales by Region
  1. 6.1 Global Albendazole Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Albendazole Sales by Region (2021-2032)
  3. 6.2.1 Global Albendazole Sales by Region (2021-2026)
  4. 6.2.2 Global Albendazole Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Albendazole Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Albendazole Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Albendazole Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Albendazole Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Albendazole Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Albendazole Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Albendazole Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Albendazole Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Albendazole Revenue by Region
  1. 7.1 Global Albendazole Revenue by Region
  2. 7.1.1 Global Albendazole Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Albendazole Revenue by Region (2021-2026)
  4. 7.1.3 Global Albendazole Revenue by Region (2027-2032)
  5. 7.1.4 Global Albendazole Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Albendazole Revenue (2021-2032)
  8. 7.2.2 North America Albendazole Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Albendazole Revenue (2021-2032)
  11. 7.3.2 Europe Albendazole Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Albendazole Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Albendazole Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Albendazole Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Albendazole Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 GlaxoSmithKline
  2. 8.1.1 GlaxoSmithKline Company Information
  3. 8.1.2 GlaxoSmithKline Business Overview
  4. 8.1.3 GlaxoSmithKline Albendazole Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 GlaxoSmithKline Albendazole Product Portfolio
  6. 8.1.5 GlaxoSmithKline Recent Developments
  7. 8.2 Huazhong Pharmaceutical
  8. 8.2.1 Huazhong Pharmaceutical Company Information
  9. 8.2.2 Huazhong Pharmaceutical Business Overview
  10. 8.2.3 Huazhong Pharmaceutical Albendazole Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Huazhong Pharmaceutical Albendazole Product Portfolio
  12. 8.2.5 Huazhong Pharmaceutical Recent Developments
  13. 8.3 Jiangsu Qihui
  14. 8.3.1 Jiangsu Qihui Company Information
  15. 8.3.2 Jiangsu Qihui Business Overview
  16. 8.3.3 Jiangsu Qihui Albendazole Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Jiangsu Qihui Albendazole Product Portfolio
  18. 8.3.5 Jiangsu Qihui Recent Developments
  19. 8.4 Sequent Scientific
  20. 8.4.1 Sequent Scientific Company Information
  21. 8.4.2 Sequent Scientific Business Overview
  22. 8.4.3 Sequent Scientific Albendazole Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sequent Scientific Albendazole Product Portfolio
  24. 8.4.5 Sequent Scientific Recent Developments
  25. 8.5 K.A. Malle Pharmaceuticals
  26. 8.5.1 K.A. Malle Pharmaceuticals Company Information
  27. 8.5.2 K.A. Malle Pharmaceuticals Business Overview
  28. 8.5.3 K.A. Malle Pharmaceuticals Albendazole Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 K.A. Malle Pharmaceuticals Albendazole Product Portfolio
  30. 8.5.5 K.A. Malle Pharmaceuticals Recent Developments
  31. 8.6 Lasa Supergenerics Limited
  32. 8.6.1 Lasa Supergenerics Limited Company Information
  33. 8.6.2 Lasa Supergenerics Limited Business Overview
  34. 8.6.3 Lasa Supergenerics Limited Albendazole Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Lasa Supergenerics Limited Albendazole Product Portfolio
  36. 8.6.5 Lasa Supergenerics Limited Recent Developments
  37. 8.7 Zhongjia Pharmaceutical
  38. 8.7.1 Zhongjia Pharmaceutical Company Information
  39. 8.7.2 Zhongjia Pharmaceutical Business Overview
  40. 8.7.3 Zhongjia Pharmaceutical Albendazole Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Zhongjia Pharmaceutical Albendazole Product Portfolio
  42. 8.7.5 Zhongjia Pharmaceutical Recent Developments
  43. 8.8 Fredun Pharmaceuticals Ltd
  44. 8.8.1 Fredun Pharmaceuticals Ltd Company Information
  45. 8.8.2 Fredun Pharmaceuticals Ltd Business Overview
  46. 8.8.3 Fredun Pharmaceuticals Ltd Albendazole Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Fredun Pharmaceuticals Ltd Albendazole Product Portfolio
  48. 8.8.5 Fredun Pharmaceuticals Ltd Recent Developments
  49. 8.9 Supharma Chem
  50. 8.9.1 Supharma Chem Company Information
  51. 8.9.2 Supharma Chem Business Overview
  52. 8.9.3 Supharma Chem Albendazole Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Supharma Chem Albendazole Product Portfolio
  54. 8.9.5 Supharma Chem Recent Developments
  55. 8.10 Salius Pharma
  56. 8.10.1 Salius Pharma Company Information
  57. 8.10.2 Salius Pharma Business Overview
  58. 8.10.3 Salius Pharma Albendazole Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Salius Pharma Albendazole Product Portfolio
  60. 8.10.5 Salius Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Albendazole Value Chain Analysis
  2. 9.1.1 Albendazole Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Albendazole Production Mode & Process
  6. 9.2 Albendazole Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Albendazole Distributors
  9. 9.2.3 Albendazole Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst